Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 allelesVivian E Saper, Michael J Ombrello, Adriana H Tremoulet, Gonzalo Montero-Martin, Sampath Prahalad, Scott Canna, Chisato Shimizu, Gail Deutsch, Serena Y Tan, Elaine F Remmers, Dimitri Monos, Timothy Hahn, Omkar K Phadke, Elaine Cassidy, Ian FergusonSee the full list of authors
17 November 2021
Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trialHafsah Nabi, Stylianos Georgiadis, Anne Gitte Loft, Oliver Hendricks, Dorte Vendelbo Jensen, Marlene Andersen, Stavros Chrysidis, Ada Colic, Kamilla Danebod, Mohamad Redha Hussein, Maren Høgberget Kalisz, Salome Kristensen, Niels Lomborg, Natalia Manilo, Heidi Lausten MunkSee the full list of authors
29 April 2021
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppressionMaria Prendecki, Candice Clarke, Helena Edwards, Stacey McIntyre, Paige Mortimer, Sarah Gleeson, Paul Martin, Tina Thomson, Paul Randell, Anand Shah, Aran Singanayagam, Liz Lightstone, Alison Cox, Peter Kelleher, Michelle WillicombeSee the full list of authors
6 August 2021
Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2Yolanda Braun-Moscovici, Marielle Kaplan, Maya Braun, Doron Markovits, Samy Giryes, Kohava Toledano, Yonit Tavor, Katya Dolnikov, Alexandra Balbir-Gurman
18 June 2021
Non-surgical and surgical treatments for rotator cuff disease: a pragmatic randomised clinical trial with 2-year follow-up after initial rehabilitationSanna Cederqvist, Tapio Flinkkilä, Markus Sormaala, Jari Ylinen, Hannu Kautiainen, Tero Irmola, Heidi Lehtokangas, Juho Liukkonen, Konsta Pamilo, Tero Ridanpää, Kai Sirniö, Juhana Leppilahti, Ilkka Kiviranta, Juha Paloneva
3 December 2020
High frequency of variants in genes associated with primary immunodeficiencies in patients with rheumatic diseases with secondary hypogammaglobulinaemiaGeorgios Sogkas, Natalia Dubrowinskaja, Ignatius Ryan Adriawan, Manfred Anim, Torsten Witte, Reinhold E Schmidt, Faranaz Atschekzei
12 October 2020
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world dataPhilip Mease, Christina Charles-Schoeman, Stanley Cohen, Lara Fallon, John Woolcott, Huifeng Yun, Joel Kremer, Jeffrey Greenberg, Wendi Malley, Alina Onofrei, Keith S Kanik, Daniela Graham, Cunshan Wang, Carol Connell, Hernan ValdezSee the full list of authors
5 August 2020
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndromeMirko Scarsi, Silvia Piantoni, Enrico Colombo, Paolo Airó, Donata Richini, Marco Miclini, Valeria Bertasi, Marta Bianchi, Damiano Bottone, Patrizia Civelli, Maria-Sofia Cotelli, Ezio Damiolini, Gloria Galbassini, Diego Gatta, Maria-Laura GhirardelliSee the full list of authors
30 July 2020
Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysisMasataka Kuwana, Christiana Blair, Tomohiko Takahashi, Jonathan Langley, John G Coghlan
11 March 2020
Chromatin interactions reveal novel gene targets for drug repositioning in rheumatic diseasesPaul Martin, James Ding, Kate Duffus, Vasanthi Priyadarshini Gaddi, Amanda McGovern, Helen Ray-Jones, Annie Yarwood, Jane Worthington, Anne Barton, Gisela Orozco
15 May 2019
